Jinwal Umesh K, Koren John, Dickey Chad A
Department of Molecular Medicine, USF Health Byrd Alzheimer's Institute, Tampa, Florida 33613.
Curr Enzym Inhib. 2013 Jan 1;9(1):41-45. doi: 10.2174/1573408011309010006.
Imbalanced protein load within cells is a critical aspect for most diseases of aging. In particular, the accumulation of proteins into neurotoxic aggregates is a common thread for a host of neurodegenerative diseases. Recent work demonstrates that age-related changes to the cellular chaperone repertoire contributes to abnormal buildup of the microtubule-associated protein tau that accumulates in a group of diseases termed tauopathies, the most common being Alzheimer's disease (AD). The Hsp90 co-chaperone repertoire has diverse effects on tau stability; some co-chaperones stabilize tau while others facilitate its clearance. We propose that each of these proteins may be novel therapeutic targets. While targeting Hsp90 directly may be deleterious at the organismal level, perhaps targeting individual co-chaperone activities will be more tolerable.
细胞内蛋白质负荷失衡是大多数衰老相关疾病的一个关键因素。特别是,蛋白质聚积形成神经毒性聚集体是许多神经退行性疾病的一个共同特征。最近的研究表明,细胞伴侣蛋白库随年龄的变化导致微管相关蛋白tau异常积聚,tau在一组称为tau蛋白病的疾病中蓄积,最常见的是阿尔茨海默病(AD)。Hsp90共伴侣蛋白库对tau稳定性有多种影响;一些共伴侣蛋白使tau稳定,而另一些则促进其清除。我们认为这些蛋白质中的每一种都可能是新的治疗靶点。虽然直接靶向Hsp90在机体水平上可能是有害的,但或许靶向单个共伴侣蛋白的活性会更具耐受性。